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Introduction / objectives
Previous skin carriage of healthcare-associated methicil-
lin-resistant Staphylococcus aureus (HA-MRSA) leads
frequently to empiric MRSA coverage for the antibiotic
treatment of skin and soft tissue infections.
Methods
Retrospective cohort study between January 1996 and
-June 2010 including adult orthopedic patients hospita-
lized at Geneva University Hospitals (MRSA prevalence;
30%).
Results
A total of 378 skin and soft tissue infections in 346
patients were retrieved. Among all episodes, 102
revealed a positive current MRSA status (during 2
weeks preceding infection; 102/378; 27%) and 70 (19%)
were MRSA carriers in the past. The sensitivity, specifi-
city, positive and negative predictive values of current
MRSA skin carriage to predict abscesses due to MRSA
were 0.68, 0.77, 0.19, and 0.97, respectively. Fifty-four
current MRSA carriers (54/102, 53%) and 30 past car-
riers (43%) were successfully treated with a non-MRSA
antibiotic agent. In multivariate Cox regression analysis,
anti-MRSA antibiotic coverage (hazard ratio 1.2, 95% CI
0.5-2.8) and duration of antibiotic therapy (HR 1.0, 95%
CI 0.96-1.02) did not influence treatment failure among
patients with positive MRSA carriage, in contrast to pre-
sence of immune suppression (HR 7.8, 95% CI 1.8-34.1).
Conclusion
Current or past HA-MRSA skin carriage poorly predicts
the need for anti-MRSA coverage for the antibiotic
treatment of skin and soft tissue infections in hospita-
lized orthopaedic patients.
Disclosure of interest
None declared.
Author details
1Surgery. Internal Medicine/Infection Control Program, Geneva University
Hospitals, Geneva, Switzerland.
2Internal Medicine, Geneva University
Hospitals, Geneva, Switzerland.
3Direction médicale/Infection Control
Program, Geneva University Hospitals, Geneva, Switzerland.
4Laboratory of
Bacteriology, Geneva University Hospitals, Geneva, Switzerland.
Published: 29 June 2011
doi:10.1186/1753-6561-5-S6-P17
Cite this article as: Uckay et al.: Carriage of healthcare-associated
methicillin-resistant Stapyloccous aureus and empiric treatment for skin
and soft tissue infections. BMC Proceedings 2011 5(Suppl 6):P17.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Surgery. Internal Medicine/Infection Control Program, Geneva University
Hospitals, Geneva, Switzerland
Full list of author information is available at the end of the article
Uckay et al. BMC Proceedings 2011, 5(Suppl 6):P17
http://www.biomedcentral.com/1753-6561/5/S6/P17
© 2011 Uckay et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.